“Retirement Secret” Showed 995% Gain Last Time We Shared It

Central Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.

Find out why right here (and see what you can do to get in too with just a few dollars).

IDYA Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 5.10%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $8,035,837.19

IDEAYA Biosciences Insider Trading History Chart

IDEAYA Biosciences Share Price & Price History

^$38.62

▼ -1.23 (-3.09%)

As of 04/25/2024 01:00 AM ET

Days: 30 | 90 | 365

“Retirement Secret” Showed 995% Gain Last Time We Shared It

From Stansberry Research | Ad

Find out why right here (and see what you can do to get in too with just a few dollars).

IDEAYA Biosciences Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/9/2024	Andres Ruiz Briseno	Insider	Sell	2,000	$46.02	$92,040.00	24,531
2/9/2024	Yujiro S. Hata	CEO	Sell	23,557	$45.54	$1,072,785.78	677,887
1/22/2024	Andres Ruiz Briseno	Insider	Sell	2,000	$42.03	$84,060.00	26,531
1/16/2024	Yujiro S. Hata	CEO	Sell	62,739	$40.17	$2,520,225.63	677,887
1/12/2024	Andres Ruiz Briseno	Insider	Sell	2,000	$38.01	$76,020.00	28,531
1/12/2024	Yujiro S. Hata	CEO	Sell	12,261	$40.04	$490,930.44	677,887
12/15/2023	Yujiro S. Hata	CEO	Sell	75,000	$35.03	$2,627,250.00	677,887
12/14/2023	Andres Ruiz Briseno	Insider	Sell	2,000	$34.00	$68,000.00	30,531
11/3/2023	Jason Throne	insider	Sell	5,163	$30.09	$155,354.67
9/12/2023	Jason Throne	insider	Sell	1,000	$30.00	$30,000.00
9/5/2023	Jason Throne	insider	Sell	1,737	$30.03	$52,162.11
9/1/2023	Jason Throne	insider	Sell	2,100	$30.03	$63,063.00	32,531
8/29/2023	Paul A. Stone	CFO	Sell	5,000	$28.87	$144,350.00	9,303
8/21/2023	Paul A. Stone	CFO	Sell	978	$26.40	$25,819.20	14,303
8/18/2023	Paul A. Stone	CFO	Sell	3,822	$26.38	$100,824.36	15,281
8/16/2023	Paul A. Stone	CFO	Sell	200	$26.43	$5,286.00	19,103
8/9/2023	Jason Throne	insider	Sell	5,000	$25.09	$125,450.00
8/9/2023	Paul A. Stone	CFO	Sell	2,500	$25.05	$62,625.00	19,303
7/10/2023	Jason Throne	insider	Sell	9,485	$23.00	$218,155.00
5/31/2023	Jason Throne	insider	Sell	432	$23.00	$9,936.00
5/22/2023	Jason Throne	insider	Sell	500	$23.00	$11,500.00
10/4/2021	Michael P. Dillon	SVP	Sell	1,500	$26.36	$39,540.00
9/7/2021	Michael P. Dillon	SVP	Sell	116	$27.46	$3,185.36	78,905
9/7/2021	Paul A. Stone	CFO	Sell	2,500	$27.42	$68,550.00	12,944
9/2/2021	Michael P. Dillon	SVP	Sell	10,000	$25.09	$250,900.00	78,789
8/9/2021	Michael P. Dillon	SVP	Sell	11,500	$22.98	$264,270.00	100,289
7/27/2021	Michael P. Dillon	SVP	Sell	10,000	$25.15	$251,500.00
7/6/2021	Michael P. Dillon	SVP	Sell	1,500	$22.24	$33,360.00	7,610
6/16/2021	Michael P. Dillon	SVP	Sell	1,107	$22.47	$24,874.29	99,896
6/7/2021	Michael P. Dillon	SVP	Sell	1,500	$20.22	$30,330.00	100,289
5/11/2021	Michael P. Dillon	SVP	Sell	5,000	$20.22	$101,100.00	103,789

“Retirement Secret” Showed 995% Gain Last Time We Shared It

From Stansberry Research | Ad

Find out why right here (and see what you can do to get in too with just a few dollars).

SEC Filings (Institutional Ownership Changes) for IDEAYA Biosciences (NASDAQ:IDYA)

98.29% of IDEAYA Biosciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

IDEAYA Biosciences Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/19/2024	JTC Employer Solutions Trustee Ltd	1,547	$67K	0.0%	N/A	0.002%
3/11/2024	Vanguard Group Inc.	3,475,772	$123.67M	0.0%	+17.0%	4.662%
3/5/2024	Fisher Asset Management LLC	539,676	$19.20M	0.0%	+1,611.9%	0.724%
3/5/2024	Wellington Management Group LLP	83,984	$2.99M	0.0%	N/A	0.113%
2/26/2024	Virtu Financial LLC	16,369	$0.58M	0.0%	N/A	0.022%
2/16/2024	Price T Rowe Associates Inc. MD	3,566,278	$126.89M	0.0%	+17.7%	5.533%
2/15/2024	Parkman Healthcare Partners LLC	130,265	$4.64M	0.7%	-1.8%	0.202%
2/15/2024	Boone Capital Management LLC	531,967	$18.93M	4.4%	-6.8%	0.825%
2/15/2024	BVF Inc. IL	1,729,043	$61.52M	1.5%	-67.3%	2.682%
2/14/2024	First Light Asset Management LLC	345,674	$12.30M	1.0%	N/A	0.536%
2/14/2024	Avidity Partners Management LP	1,520,000	$54.08M	2.0%	-29.1%	2.358%
2/14/2024	Superstring Capital Management LP	251,295	$8.94M	6.4%	N/A	0.390%
2/14/2024	Platinum Investment Management Ltd.	662,343	$23.57M	1.0%	-13.6%	1.028%
2/13/2024	Capital Research Global Investors	1,976,870	$70.34M	0.0%	+43.6%	3.067%
2/13/2024	Rafferty Asset Management LLC	193,356	$6.88M	0.0%	+49.8%	0.300%
2/13/2024	Campbell & CO Investment Adviser LLC	61,226	$2.18M	0.2%	+93.2%	0.095%
2/12/2024	Redmond Asset Management LLC	12,794	$0.46M	0.1%	-1.9%	0.020%
2/12/2024	Capstone Investment Advisors LLC	55,239	$1.97M	0.0%	N/A	0.086%
2/12/2024	TD Asset Management Inc	137,690	$4.90M	0.0%	+21.1%	0.214%
2/9/2024	Franklin Resources Inc.	27,237	$0.97M	0.0%	+4.9%	0.042%
2/9/2024	Trexquant Investment LP	21,984	$0.78M	0.0%	+32.8%	0.034%
2/8/2024	Nicholas Investment Partners LP	110,351	$3.93M	0.5%	N/A	0.171%
2/8/2024	First Turn Management LLC	382,382	$13.61M	2.0%	N/A	0.593%
2/8/2024	Mitsubishi UFJ Asset Management Co. Ltd.	5,799	$0.20M	0.0%	-40.4%	0.009%
2/7/2024	Dimensional Fund Advisors LP	1,286,300	$45.77M	0.0%	+12.6%	1.996%
2/7/2024	Jump Financial LLC	6,045	$0.22M	0.0%	N/A	0.009%
2/7/2024	BNP Paribas Financial Markets	207,735	$7.39M	0.0%	+295.3%	0.322%
2/7/2024	Teacher Retirement System of Texas	10,242	$0.36M	0.0%	-25.5%	0.016%
2/7/2024	E Fund Management Co. Ltd.	10,385	$0.37M	0.0%	N/A	0.016%
2/6/2024	Charles Schwab Investment Management Inc.	496,456	$17.66M	0.0%	+13.5%	0.770%
2/6/2024	AJOVista LLC	2,778	$99K	0.1%	N/A	0.004%
2/6/2024	Swiss National Bank	85,100	$3.03M	0.0%	-20.5%	0.132%
2/6/2024	Fisher Asset Management LLC	539,025	$19.18M	0.0%	+1,609.8%	0.836%
2/5/2024	Victory Capital Management Inc.	346,490	$12.33M	0.0%	N/A	0.538%
2/2/2024	Callan Capital LLC	6,726	$0.24M	0.0%	N/A	0.010%
2/1/2024	New York State Common Retirement Fund	40,657	$1.45M	0.0%	+98.6%	0.063%
1/31/2024	Federated Hermes Inc.	3,883,775	$138.19M	0.3%	+14.8%	6.025%
1/30/2024	Zurcher Kantonalbank Zurich Cantonalbank	18,797	$0.67M	0.0%	+2.7%	0.029%
1/24/2024	Mirae Asset Global Investments Co. Ltd.	35,346	$1.26M	0.0%	+16.8%	0.055%
1/24/2024	Arizona State Retirement System	12,069	$0.43M	0.0%	-13.0%	0.019%
1/24/2024	China Universal Asset Management Co. Ltd.	7,453	$0.27M	0.1%	+405.6%	0.012%
1/16/2024	Legato Capital Management LLC	12,494	$0.45M	0.1%	N/A	0.019%
1/11/2024	Ziegler Capital Management LLC	12,620	$0.45M	0.0%	-56.0%	0.020%
1/5/2024	Exchange Traded Concepts LLC	4,806	$0.17M	0.0%	+34.0%	0.007%
12/18/2023	Vanguard Group Inc.	2,971,497	$80.17M	0.0%	+5.0%	4.610%
12/7/2023	Hudson Bay Capital Management LP	35,000	$0.94M	0.0%	N/A	0.054%
11/21/2023	Walleye Capital LLC	83,963	$2.27M	0.0%	N/A	0.130%
11/15/2023	Adage Capital Partners GP L.L.C.	2,286,961	$61.70M	0.1%	-11.2%	3.548%
11/15/2023	Alps Advisors Inc.	42,479	$1.15M	0.0%	+0.9%	0.066%
11/14/2023	Eventide Asset Management LLC	335,000	$9.04M	0.2%	N/A	0.520%
11/14/2023	Schonfeld Strategic Advisors LLC	32,848	$0.89M	0.0%	-51.9%	0.051%
11/14/2023	Fred Alger Management LLC	13,470	$0.36M	0.0%	N/A	0.021%
11/14/2023	Boone Capital Management LLC	570,682	$15.40M	4.9%	+15.0%	0.885%
11/14/2023	Avidity Partners Management LP	2,144,971	$57.87M	2.3%	-28.2%	3.328%
11/14/2023	Trexquant Investment LP	16,552	$0.45M	0.0%	-67.7%	0.026%
11/14/2023	Profund Advisors LLC	22,343	$0.60M	0.0%	-4.0%	0.035%
11/13/2023	Algert Global LLC	42,619	$1.15M	0.1%	-34.5%	0.066%
11/13/2023	EAM Investors LLC	87,662	$2.37M	0.5%	+147.9%	0.136%
11/13/2023	Federated Hermes Inc.	3,383,729	$91.29M	0.2%	-0.2%	5.249%
11/13/2023	Hsbc Holdings PLC	13,399	$0.36M	0.0%	N/A	0.021%
11/13/2023	Aigen Investment Management LP	8,950	$0.24M	0.0%	N/A	0.014%
11/13/2023	Invesco Ltd.	290,267	$7.83M	0.0%	+26.7%	0.450%
11/13/2023	Rafferty Asset Management LLC	129,076	$3.48M	0.0%	+3.2%	0.200%
11/9/2023	Rhumbline Advisers	78,794	$2.13M	0.0%	+2.4%	0.137%
11/9/2023	Deutsche Bank AG	29,909	$0.81M	0.0%	+15.7%	0.052%
11/9/2023	Citigroup Inc.	55,254	$1.49M	0.0%	+3.7%	0.096%
11/8/2023	Campbell & CO Investment Adviser LLC	31,690	$0.86M	0.1%	+49.6%	0.055%
11/8/2023	Charles Schwab Investment Management Inc.	437,356	$11.80M	0.0%	+199.3%	0.760%
11/8/2023	Swiss National Bank	107,000	$2.89M	0.0%	+3.6%	0.186%
11/8/2023	Amalgamated Bank	7,205	$0.19M	0.0%	+6.4%	0.013%
11/7/2023	Virtus ETF Advisers LLC	3,977	$0.11M	0.1%	-9.2%	0.007%
11/7/2023	Barclays PLC	86,326	$2.33M	0.0%	+17.8%	0.150%
11/7/2023	Arizona State Retirement System	13,865	$0.37M	0.0%	+4.0%	0.024%
11/7/2023	Mitsubishi UFJ Kokusai Asset Management Co. Ltd.	9,735	$0.26M	0.0%	+6.1%	0.017%
11/6/2023	Los Angeles Capital Management LLC	18,802	$0.51M	0.0%	+2.5%	0.033%
11/3/2023	Platinum Investment Management Ltd.	766,682	$20.69M	0.8%	-5.9%	1.332%
11/2/2023	Principal Financial Group Inc.	14,415	$0.39M	0.0%	+4.9%	0.025%
11/1/2023	Jacob Asset Management of New York LLC	34,103	$0.92M	1.3%	-12.6%	0.059%
10/31/2023	Teacher Retirement System of Texas	13,741	$0.37M	0.0%	+6.7%	0.024%
10/31/2023	China Universal Asset Management Co. Ltd.	1,474	$40K	0.0%	+96.3%	0.003%
10/27/2023	Allspring Global Investments Holdings LLC	3,599	$97K	0.0%	-48.2%	0.006%
10/27/2023	TD Asset Management Inc	113,656	$3.07M	0.0%	+206.1%	0.197%
10/25/2023	Zurcher Kantonalbank Zurich Cantonalbank	18,311	$0.49M	0.0%	-6.9%	0.032%
10/24/2023	Bank of New York Mellon Corp	196,289	$5.30M	0.0%	+12.7%	0.341%
10/18/2023	Exchange Traded Concepts LLC	3,587	$97K	0.0%	-36.5%	0.006%
10/16/2023	Ziegler Capital Management LLC	28,712	$0.78M	0.0%	-8.3%	0.050%
10/13/2023	SG Americas Securities LLC	21,025	$0.57M	0.0%	N/A	0.037%
9/21/2023	Halpern Financial Inc.	2,250	$53K	0.0%	N/A	0.004%
9/8/2023	Tucker Asset Management LLC	2,813	$66K	0.0%	+1,265.5%	0.005%
8/15/2023	Boone Capital Management LLC	496,433	$11.67M	4.2%	N/A	0.862%
8/15/2023	BVF Inc. IL	5,683,489	$133.56M	3.7%	+131.5%	9.874%
8/15/2023	Commodore Capital LP	775,000	$18.21M	2.0%	N/A	1.346%
8/14/2023	Cormorant Asset Management LP	600,000	$14.10M	0.8%	+71.4%	1.042%
8/14/2023	UniSuper Management Pty Ltd	111,344	$2.62M	0.0%	N/A	0.193%
8/14/2023	Driehaus Capital Management LLC	262,436	$6.17M	0.1%	N/A	0.456%
8/14/2023	Ghisallo Capital Management LLC	37,500	$0.88M	0.1%	N/A	0.065%
8/11/2023	Campbell & CO Investment Adviser LLC	21,184	$0.50M	0.1%	N/A	0.037%
8/11/2023	Trexquant Investment LP	51,239	$1.20M	0.0%	N/A	0.089%
8/11/2023	Capital Research Global Investors	723,802	$17.01M	0.0%	N/A	1.263%
8/11/2023	Platinum Investment Management Ltd.	814,670	$19.15M	0.7%	-2.5%	1.422%

Data available starting January 2016

IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, discovers and develops targeted therapeutics for patient populations selected using molecular diagnostics in the United States. The company's products in development include IDE196, a protein kinase C inhibitor that is in Phase 2/3 clinical trials for genetically defined cancers having GNAQ or GNA11 gene mutations; IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase 1/2 clinical trials for patients with solid tumors having methylthioadenosine phosphorylase gene deletions, such as non-small cell lung, bladder, gastric, and esophageal cancers; IDE161, a poly ADP-ribose glycohydrolase inhibitor that is in Phase 1 clinical trial to treat tumors with homologous recombination deficiency (HRD), and other genetic or molecular signatures; GSK101, a Pol Theta Helicase inhibitor that is in Phase 1 clinical trial for the treatment of tumors with BRCA or other homologous recombination, and HRD mutations; and Werner Helicase inhibitors for tumors with high microsatellite instability. It offers preclinical research programs focused on pharmacological inhibition; DECIPHER dual CRISPR library for synthetic lethality target and biomarker discovery; and INQUIRE chemical library and HARMONY machine-learning engines to enhance its drug discovery platform. The company has strategic alliances with GlaxoSmithKline, Pfizer Inc., Novartis International Pharmaceuticals Ltd., Amgen Inc., Gilead Sciences, Inc., Cancer Research UK, and the University of Manchester. IDEAYA Biosciences, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.

Today's Range

Now: $38.62

$37.81

$39.93

50 Day Range

MA: $43.28

$37.13

$47.13

52 Week Range

Now: $38.62

$18.09

$47.74

Volume

734,655 shs

Average Volume

563,509 shs

Market Capitalization

$2.89 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.8

Who are the company insiders with the largest holdings of IDEAYA Biosciences?: IDEAYA Biosciences' top insider investors include:
Yujiro S Hata (CEO)
Jason Throne (Insider)
Briseno Andres Ruiz (Insider)
Paul A Stone (CFO)
Learn More about top insider investors at IDEAYA Biosciences.
Who are the major institutional investors of IDEAYA Biosciences?: IDEAYA Biosciences' top institutional shareholders include:
JTC Employer Solutions Trustee Ltd — 0.00%
Learn More about top institutional investors of IDEAYA Biosciences stock.
Which institutional investors are buying IDEAYA Biosciences stock?: In the previous quarter, IDYA stock was purchased by institutional investors including:
JTC Employer Solutions Trustee Ltd

“Retirement Secret” Showed 995% Gain Last Time We Shared It

From Stansberry Research | Ad

Find out why right here (and see what you can do to get in too with just a few dollars).

IDYA Insider Trading

IDEAYA Biosciences Insider Trading History Chart

IDEAYA Biosciences Share Price & Price History

IDEAYA Biosciences Insider Trading History

SEC Filings (Institutional Ownership Changes) for IDEAYA Biosciences (NASDAQ:IDYA)

Institutional Buying and Selling by Quarter

IDEAYA Biosciences Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of IDEAYA Biosciences?

Who are the major institutional investors of IDEAYA Biosciences?

Which institutional investors are buying IDEAYA Biosciences stock?